Skip to main content

Peer Review reports

From: Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz + lamivudine + tenofovir disoproxil among HIV-1 patients newly starting treatment in Hunan Province in China

Original Submission
6 Dec 2022 Submitted Original manuscript
12 Feb 2023 Reviewed Reviewer Report
19 Feb 2023 Reviewed Reviewer Report
3 Apr 2023 Author responded Author comments - Guoqiang Zhou
Resubmission - Version 2
3 Apr 2023 Submitted Manuscript version 2
17 Apr 2023 Reviewed Reviewer Report
10 May 2023 Author responded Author comments - Guoqiang Zhou
Resubmission - Version 3
10 May 2023 Submitted Manuscript version 3
Publishing
31 May 2023 Editorially accepted
12 Jun 2023 Article published 10.1186/s12879-023-08359-w

You can find further information about peer review here.

Back to article page